Anaconda: I think I've felt the same way. No doubt Gerald has had to do some slight of hand magic to keep shareholders spellbound over the past 2 years. I think that is what penny stock biotech CEOs have to do.....it's a part of the job description.

But....at the same time he really has done a great job amassing the pipeline. Am I upset over how my investment has performed over the past 18 months compared to the expectations Gerald built? Yes. But am I willing to sell? No.

I think small biotechs are like hot dog manufacturers.....it's best not to know what goes on behind the scenes. I still believe in AMBS' end product. Many are here for MANF primarily. I like MANF, but I'm here for the short term pop from the Diagnostic Division. I think 2015 will please us....sooner or later.

But I'm a long term holder. I don't think I'd rather be anywhere else, in spite of the delays.